Member Info for gggg21

Manifesto to answer point 1) who bought the shares in the bookbuild. We know lansdowne partners took more, so did the board and employees. I also know polar capital took a load to. It’s very nice having some IIs on board and taking stakes.

https://medium.com/@irstaxapp/5-drugs-showing-promise-as-a-coronavirus-cure-a5de47952583

Boom time again Tuesday and probably all of next week. Well done bladedsharp for providing the input here yet again and doing proper research.

Trek it is 100 patients in the upto 64 category and 300 in the over 65 category. Now across 20 sites. I don’t remember reading those 2 before and it differs from the rns. As this site is correct and regulated it does seem like the trial has evolved, maybe wrong but I only briefly viewed this couple of weeks back when it appeared

Here you go Trek complete breakdown -https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001023-14/GB I am not sure when all this got updated and if it has been but it looks different to what I originally read couple of weeks ago. I had a little panic yesterday when I could not find the trial on the normal search but that is because it has been moved to under "covid19 trials" with the rest of these https://www.clinicaltrialsregister.eu/ctr-search/search?query=covid-19&page=2
56 trials on going in EU and we were one of the first to start which is nice.

What are you on about, I think you’re confused and wrong sorry. https://www.lansdownepartners.com/ own the shares

Lol. It shouldn’t have taken you to long to deduce. They have nothing yet, extract from the article right at the top you posted - “ A word of caution here, the treatment known as TZLS-501 is still at a fledgling stage of development.”

No product, no approval, no stage 1 trial let alone active stage 2 trial like sng. Those rns for companies like tils I call Jam

From the fundraising rns and what I alluded to earlier.
In addition, Lansdowne Partners Ltd ("Lansdowne") is a substantial shareholder in the Company holding 10 per cent. or more of the existing issued Ordinary Shares and has agreed to subscribe for 4,285,714 Placing Shares at the Issue Price, representing 10.7 per cent. of the total New Ordinary Shares.

Loc the poster is making it up. They posted on 10th. Is it to late to buy lol

Some good posts and research here today. Nice to see. This was a nice extract from the rns
SNG001 was identified in the WHO's Landscape analysis of therapeutics as at 17 February 2020 as the only Phase 2/Phase 3/Observational therapy delivered by the inhaled route (https://www.who.int/blueprint/priority-diseases/key-action/Table_of_therapeutics_Appendix_17022020.pdf?ua=1).



Two Phase II clinical trials in asthma showed that inhaled SNG001 treatment activated antiviral pathways in the lung along with improving lung function in patients with a respiratory viral infection. We have also shown that treatment with inhaled SNG001 reduced lung viral load and lung pathology in an in vivo swine flu driven model of viral pneumonia. At the time of the MERS-CoV outbreak in 2013, Synairgen collaborated with the National Institutes of Health (NIH) in the US to show that SNG001 could protect against MERS-CoV infection of lung cells in vitro.

A nice tick in the box for me making me a more relaxed holder here is that the fundraising and placing is done, out of the way now so no need to worry about that. Anyone have an idea how many patients have been dosed so far? I would think that by the time markets open on Tuesday we could be very close to the 100 target and get an rns for that.

The way I see it is that for a company of this size to go and raise 14m in an oversubscribed bookbuild overnight and lansdowne to actually want more is very very positive. To also already be planning manufacturing and supply chain another good sign with not just one but multiple flagship nhs trusts to take it on. Odds look very good

Yep agree miggy. Southampton dosed 31st, I know other hospitals like Leicester Nottingham Birmingham were always planned to be added on and dosed and it was nice to read that this is on going with the doctor from Birmingham tweeting excitement on the 8th to join the trial and start. If you gon Leicester uni hospital research site they are only running two trials all others cancelled and ours continues which again shows the focus and commitment. This is aim and looking at it from my experience I expect a mm/broker led pump at the very least to coincide with Tuesday 14th hence the movements or lack of on Thursday and company update to give those new holders updates to coincide with them taking millions of shares. At the very least we are going to get a tr1 Tuesday/Wednesday which should be interesting. Nobody bar the diestressed seller across the market, Richard Griffiths, has sold. He has liquidated nearly all his holdings in all companies just look at JOG.

It was never on there it was a mistake. We keep covering this time and time again. Read back through last nights posts. Sng trial is on going, more hospitals dosing their first patients like Birmingham on the 8th and with the egm on Tuesday and 14 days since first dosing in Southampton no doubt there may well be a little update. The trial for individuals in 14 days is it not? Could also have further updates on approaches from other health agencies etc.

Skittish. You got the jist however Primerdesign “test” is part of the process the tests itself sells between £8.50 and £14.50 per unit depending on the exchange rate fluctuations and reseller. The price you are quoting is for the “whole complete test” so that’s from swab to test to run time on equipment by qualified staff to analysis to given results. Hence the large price due to all the element, resource (machine to run it on) and trained staff.

The reason why we are not mass testing.....yet....is we have been sourcing all the labs, staffs, machines etc. Today’s news about another mini kit that our genesig test can be used on is big. Two reasons 1) it can be used in small “local labs” 2) it is being mass used in the US hence meaning more sales. Bring in next week we will fly

Correct me if I’m wrong but we were never part of this collected trial to start with it is all being run by oxford university. We aren’t. We are with Southampton uni, Leicester, Nottingham. Birmingham University hospital started dosing sng001 on their first patient 8th April

Fat fingers https://www.qiagen.com/gb/products/discovery-and-translational-research/dna-rna-purification/rna-purification/total-rna/rneasy-mini-kit/?clear=true#orderinginformation

This is the good news behind it. Top seller https://www.qiagen.com/gb/products/top-sellers/qiaamp-dna-mini-kit/#orderinginformation

https://tunein.com/podcasts/Business-News/Business-Daily-p114784/?topicId=140873681

Just a recap for anyone who is late here and missed it. The bbc business daily interview with Richard our ceo talking about the trial and manufacturing. Around 12mins in

A bit like the government ordering all those antibody tests prior to testing them....sng already as per rns put money aside for supplies and manufacturing

I’ll come down I love a challenge and sport, never played rugby always football, cricket, boxing and hockey. I’ll even buy you a beer in the bar after I have no hard feelings I simply stated my worry at the time and you kept poking. I’m west London so no idea how far but first trip is on a plane to my White Island just not a Flybe one eh